Distalmotion, a robot surgical treatment firm, has actually obtained FDA 510( k) clearance for using its Dexter Robotic Surgical procedure System in grown-up cholecystectomy (gallbladder elimination). This turning point stands for the 2nd authorized indicator in the United States, adhering to Afresh clearance for inguinal rupture repair service in Q4 2024. Greg Roche, Chief Executive Officer of Distalmotion, claims: “Cholecystectomy is a crucial […].
发布者：Sam Francis，转转请注明出处：https://robotalks.cn/distalmotion-gains-fda-clearance-for-robotic-surgery-system/
